ADENOCARD Drug Patent Profile
✉ Email this page to a colleague
When do Adenocard patents expire, and what generic alternatives are available?
Adenocard is a drug marketed by Astellas and is included in one NDA.
The generic ingredient in ADENOCARD is adenosine. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adenocard
A generic version of ADENOCARD was approved as adenosine by HIKMA on June 16th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ADENOCARD?
- What are the global sales for ADENOCARD?
- What is Average Wholesale Price for ADENOCARD?
Summary for ADENOCARD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 115 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,668 |
| Drug Prices: | Drug price information for ADENOCARD |
| What excipients (inactive ingredients) are in ADENOCARD? | ADENOCARD excipients list |
| DailyMed Link: | ADENOCARD at DailyMed |
Recent Clinical Trials for ADENOCARD
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Colorado State University | Early Phase 1 |
| University of Utah | Early Phase 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | Early Phase 1 |
US Patents and Regulatory Information for ADENOCARD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astellas | ADENOCARD | adenosine | INJECTABLE;INJECTION | 019937-002 | Oct 30, 1989 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ADENOCARD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Astellas | ADENOCARD | adenosine | INJECTABLE;INJECTION | 019937-002 | Oct 30, 1989 | 4,673,563 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
